We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Compound danshen tablet ameliorated abeta25-35-induced spatial memory impairment in mice via rescuing imbalance between cytokines and neurotrophins.
- Authors
Yan Teng; Meng-Qi Zhang; Wen Wang; Li-Tao Liu; Li-Ming Zhou; Shi-Kun Miao; Li-Hong Wan
- Abstract
Background Compound Danshen Tablet (CDT), a Traditional Chinese Medicine, has recently been reported to improve spatial cognition in a rat model of Alzheimer’s disease. However, in vivo neuroprotective mechanism of the CDT in models of spatial memory impairment is not yet evaluated. The present study is aimed to elucidate the cellular mechanism of CDT on Aβ25-35- induced cognitive impairment in mice. Methods Mice were randomly divided into 5 groups: the control group (sham operated), the Aβ 25-35 treated group, the positive drug group, and large and small dosage of the CDT groups, respectively. CDT was administered at a dose of 0.81 g/kg and 0.405 g/kg for 3 weeks. The mice in the positive drug group were treated with 0.4 mg/kg of Huperzine A, whereas the mice of the control and Aβ 25-35 treated groups were administrated orally with equivalent saline. After 7 days of preventive treatment, mice were subjected to lateral ventricle injection of Aβ 25-35 to establish the mice model of Alzheimer’s disease. Spatial memory impairment was evaluated by Morris water maze test. Choline acetyltransferase (ChAT) contents in hippocampus and cortex were quantified by ELISA. The levels of cytokines, receptor of activated protein kinase C1 (RACK1) and brain-derived neurotrophic factor (BDNF) in hippocampus were measured by RT-PCR and ELISA. Results The results showed that Aβ 25-35 caused spatial memory impairment as demonstrated by performance in the Morris water maze test. CDT was able to confer a significant improvement in spatial memory, and protect mice from Aβ 25-35-induced neurotoxicity. Additionally, CDT also inhibited the increase of TNF-α and IL-6 level, and increased the expression of choline acetyltransferase (ChAT), receptor of activated protein kinase C1 (RACK1) and brain-derived neurotrophic factor (BDNF) in brain as compared to model mice. Conclusion These findings strongly implicate that CDT may be a useful treatment against learning and memory deficits in mice by rescuing imbalance between cytokines and neurotrophins.
- Subjects
ALZHEIMER'S disease; ANALYSIS of variance; ANIMAL experimentation; ENZYME-linked immunosorbent assay; HERBAL medicine; HISTOLOGICAL techniques; CHINESE medicine; MEMORY; MICE; POLYMERASE chain reaction; RESEARCH funding; STATISTICAL sampling; PERCEPTUAL disorders; DESCRIPTIVE statistics
- Publication
BMC Complementary & Alternative Medicine, 2014, Vol 14, Issue 1, p23
- ISSN
1472-6882
- Publication type
Article
- DOI
10.1186/1472-6882-14-23